Overweight, hypertension and renal dysfunction in adulthood of neonatally overfed rats

Journal of Nutritional Biochemistry

Volumn 24, Issue 7, 2013, Pages 1324-1333

  Yim, Hyung Eun ^a   Ha, Kee Soo ^a   Bae, In Sun ^a   Yoo, Kee Hwan ^a   Hong, Young Sook ^a   Lee, Joo Won ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Chronic renal insufficiency; Hypertension; Obesity; Overnutrition; Postnatal growth

Indexed keywords

ADIPONECTIN; CREATININE; GELATINASE B; INTERSTITIAL COLLAGENASE; OSTEOPONTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULTHOOD; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEVELOPMENT; HYPERTENSION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY CORTEX; KIDNEY DYSFUNCTION; MACROPHAGE; MALE; NEWBORN PERIOD; NONHUMAN; OBESITY; OVERNUTRITION; PROTEIN EXPRESSION; RAT; ANIMAL; APOPTOSIS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; GENETICS; GLOMERULONEPHRITIS; NEWBORN; OVERWEIGHT; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; GLOMERULONEPHRITIS; HYPERTENSION; MALE; OVERWEIGHT; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84879289327     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.10.007     Document Type: Article

References (48)

1. Sullivan E.L., Grove K.L. Metabolic imprinting in obesity. Forum Nutr 2010, 63:186-194.
2. Ekelund U., Ong K., Linné Y., Neovius M., Brage S., Dunger D.B., et al. Upward weight percentile crossing in infancy and early childhood independently predicts fat mass in young adults: the Stockholm Weight Development Study (SWEDES). Am J Clin Nutr 2006, 83:324-330.
3. Vickers M.H., Breier B.H., Cutfield W.S., Hofman P.L., Gluckman P.D. Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J Physiol Endocrinol Metab 2000, 279:E83-E87.
4. Stettler N., Stallings V.A., Troxel A.B., Zhao J., Schinnar R., Nelson S.E., et al. Weight gain in the first week of life and overweight in adulthood: a cohort study of European American subjects fed infant formula. Circulation 2005, 111:1897-1903.
5. Plagemann A., Harder T., Rake A., Voits M., Fink H., Rohde W., et al. Perinatal elevation of hypothalamic insulin, acquired malformation of hypothalamic galaninergic neurons, and syndrome x-like alterations in adulthood of neonatally overfed rats. Brain Res 1999, 836:146-155.
6. Morris M.J., Velkoska E., Cole T.J. Central and peripheral contributions to obesity-associated hypertension: impact of early overnourishment. Exp Physiol 2005, 90:697-702.
7. Yim H.E., Ha K.S., Bae I.S., Yoo K.H., Hong Y.S., Lee J.W. Postnatal early overnutrition dys-regulates intrarenal renin angiotensin system and extracellular matrix-linked molecules in juvenile male rats. J Nutr Biochem 2012, 23:937-945.
8. Foster M.C., Hwang S.J., Larson M.G., Lichtman J.H., Parikh N.I., Vasan R.S., et al. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis 2008, 52:39-48.
9. Flegal K.M., Carroll M.D., Ogden C.L., Curtin L.R. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010, 20(303):235-241.
10. Navarro-Díaz M., Serra A., López D., Granada M., Bayés B., Romero R. Obesity, inflammation, and kidney disease. Kidney Int 2008, 111:S15-S18.
11. Wisse B.E. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004, 15:2792-2800.
12. Wahba I.M., Mak R.H. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol 2007, 2:550-562.
13. Griffin K.A., Kramer H., Bidani A.K. Adverse renal consequences of obesity. Am J Physiol Renal Physiol 2008, 294:685-696.
14. Nenov V.D., Taal M.W., Sakharova O.V., Brenner B.M. Multi-hit nature of chronic renal disease. Curr Opin Nephrol Hypertens 2000, 9:85-97.
15. Singhal A., Cole T.J., Fewtrell M., Deanfield J., Lucas A. Is slower early growth beneficial for long-term cardiovascular health?. Circulation 2004, 109:1108-1113.
16. Singhal A., Cole T.J., Fewtrell M., Kennedy K., Stephenson T., Elias-Jones A., et al. Promotion of faster weight gain in infants born small for gestational age: is there an adverse effect on later blood pressure?. Circulation 2007, 115:213-220.
17. Boubred F., Buffat C., Feuerstein J.M., Daniel L., Tsimaratos M., Oliver C., et al. Effects of early postnatal hypernutrition on nephron number and long-term renal function and structure in rats. Am J Physiol Renal Physiol 2007, 293:1944-1949.
18. Boubred F., Daniel L., Buffat C., Feuerstein J.M., Tsimaratos M., Oliver C., et al. Early postnatal overfeeding induces early chronic renal dysfunction in adult male rats. Am J Physiol Renal Physiol 2009, 297:943-951.
19. Choi B.M., Yoo K.H., Bae I.S., Oh M.H., Hong Y.S., Lee J.W., et al. Angiotensin-converting enzyme inhibition modulates mitogen-activated protein kinase family expressions in the neonatal rat kidney. Pediatr Res 2005, 57:115-123.
20. Yim H.E., Yoo K.H., Bae I.S., Jang G.Y., Hong Y.S., Lee J.W. Aldosterone regulates cellular turnover and mitogen-activated protein kinase family expression in the neonatal rat kidney. J Cell Physiol 2009, 219:724-733.
21. Ma L.J., Nakamura S., Aldigier J.C., Rossini M., Yang H., Liang X., et al. Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1. J Am Soc Nephrol 2005, 16:966-976.
22. Plagemann A. Perinatal programming and functional teratogenesis: impact on body weight regulation and obesity. Physiol Behav 2005, 86:661-668.
23. Henegar J.R., Bigler S.A., Henegar L.K., Tyagi S.C., Hall J.E. Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 2001, 12:1211-1217.
24. Tarry-Adkins J.L., Joles J.A., Chen J.H., Martin-Gronet M.S., van der Giezen D.M., Goldschmeding R.R., et al. Protein restriction in lactation confers nephroprotective effects in the male rat and is associated with increased antioxidant expression. Am J Physiol Regul Integr Comp Physiol 2007, 293:1259-1266.
25. Nieto-Vazquez I., Fernández-Veledo S., Krämer D.K., Vila-Bedmar R., Garcia-Guerra L., Lorenzo M. Insulin resistance associated to obesity: the link TNF-alpha. Arch Physiol Biochem 2008, 114:183-194.
26. Klahr S., Morrissey J. Progression of chronic renal disease. Am J Kidney Dis 2003, 41:S3-S7.
27. Wolak T., Kim H., Ren Y., Kim J., Vaziri N.D., Nicholas S.B. Osteopontin modulates angiotensin II-induced inflammation, oxidative stress, and fibrosis of the kidney. Kidney Int 2009, 76:32-43.
28. Li C., Yang C.W., Park C.W., Ahn H.J., Kim W.Y., Yoon K.H., et al. Long-term treatment with ramipril attenuates renal osteopontin expression in diabetic rats. Kidney Int 2003, 63:454-463.
29. Esposito K., Giugliano G., Scuderi N., Giugliano D. Role of adipokines in the obesity-inflammation relationship: the effect of fat removal. Plast Reconstr Surg 2006, 118:1048-1057.
30. Kojima S., Funahashi T., Otsuka F., Maruyoshi H., Yamashita T., Kajiwara I., et al. Future adverse cardiac events can be predicted by persistently low plasma adiponectin concentrations in men and marked reductions of adiponectin in women after acute myocardial infarction. Atherosclerosis 2007, 194:204-213.
31. Koshimura J., Fujita H., Narita T., Shimotomai T., Hosoba M., Yoshioka N., et al. Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy. Biochem Biophys Res Commun 2004, 316:165-169.
32. Jorsal A., Tarnow L., Frystyk J., Lajer M., Flyvbjerg A., Parving H.H., et al. Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy. Kidney Int 2008, 74:649-654.
33. Sharma K., Ramachandrarao S., Qiu G., Usui H.K., Zhu Y., Dunn S.R., et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 2008, 118:1645-1656.
34. Nagase H., Woessner J.F. Matrix metalloproteinases. J Biol Chem 1999, 274:21491-21494.
35. Lelongt B., Legallicier B., Piedagnel R., Ronco P.M. Do matrix metalloproteinases MMP-2 and MMP-9 (gelatinases) play a role in renal development, physiology and glomerular diseases?. Curr Opin Nephrol Hypertens 2001, 10:7-12.
36. Catania J.M., Chen G., Parrish A.R. Role of matrix metalloproteinases in renal pathophysiologies. Am J Physiol Renal Physiol 2007, 292:905-911.
37. Duong Van Huyen J.P., Viltard M., Nehiri T., Freund N., Bélair M.F., Martinerie C., et al. Expression of matrix metalloproteinases MMP-2 and MMP-9 is altered during nephrogenesis in fetuses from diabetic rats. Lab Invest 2007, 87:680-689.
38. McLennan S.V., Wang X.Y., Moreno V., Yue D.K., Twigg S.M. Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy. Endocrinology 2004, 145:5646-5655.
39. Han S.Y., Jee Y.H., Han K.H., Kang Y.S., Kim H.K., Han J.Y., et al. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy. Nephrol Dial Transplant 2006, 21:2406-2416.
40. Ronco P., Chatziantoniou C. Matrix metalloproteinases and matrix receptors in progression and reversal of kidney disease: therapeutic perspectives. Kidney Int 2008, 74:873-878.
41. Ronco P., Lelongt B., Piedagnel R., Chatziantoniou C. Matrix metalloproteinases in kidney disease progression and repair: a case of flipping the coin. Semin Nephrol 2007, 27:352-362.
42. Zeisberg M., Khurana M., Rao V.H., Cosgrove D., Rougier J.P., Werner M.C., et al. Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease. PLoS Med 2006, 3:e100.
43. Woods L.L., Weeks D.A., Rasch R. Programming of adult blood pressure by maternal protein restriction: role of nephrogenesis. Kidney Int 2004, 65:1339-1348.
44. Simeoni U., Ligi I., Buffat C., Boubred F. Adverse consequences of accelerated neonatal growth: cardiovascular and renal issues. Pediatr Nephrol 2011, 26:493-508.
45. Boullu-Ciocca S., Dutour A., Guillaume V., Achard V., Oliver C., Grino M. Postnatal diet-induced obesity in rats upregulates systemic and adipose tissue glucocorticoid metabolism during development and in adulthood: its relationship with the metabolic syndrome. Diabetes 2005, 54:197-203.
46. Gluckman P.D., Hanson M. Mismatch: why our world no longer fits our bodies 2006, Oxford University Press, Oxford, pp. 285.
47. Koeners M.P., Joles J.A. A fat chance of renal injury. Kidney Int 2007, 72:232-234.
48. Williams P.J., Kurlak L.O., Perkins A.C., Budge H., Stephenson T., Keisler D., et al. Hypertension and impaired renal function accompany juvenile obesity: the effect of prenatal diet. Kidney Int 2007, 72:279-289.